Mylan Laboratories has supplemented a petition with the FDA, seeking an immediate response to its claim that branded drugmakers are unfairly undermining sales of generic drugmakers.
A U.S. district court has cleared Barr Laboratories of infringing three patents at the center of the generic drug maker’s challenge involving Aventis’ Allegra blockbuster allergy drug.
A federal judge has dismissed biotech company Promega Corp.'s lawsuit in a long-running legal battle against rival Hoffmann LaRoche and its partner, Applera Corp, but Promega two weeks to provide additional details in an amended lawsuit.
A U.S. district court judge has ruled that Pfizer’s patents for Accupril are valid, dealing Israeli drug maker Teva a blow in its efforts to market a generic version of the $600 million blood pressure medicine.
A U.S. appeals court has paved the way for Xechem International to seek treble damages in an antitrust suit against drug maker Bristol-Myers Squibb over its alleged efforts to thwart generic competition for the cancer drug Taxol.
An Australian parliamentary committee has urged the federal government to rewrite copyright laws to soften the impact of the planned free trade agreement with the U.S.
The U.S. Court of Appeals for the Federal Circuit has overturned a lower court’s ruling of no infringement under the doctrine of equivalents in biopharma company Immunomedics’ patent lawsuit against rivals Cytogen Corp. and C.R. Bard.
In a patent settlement that has taken many observers by surprise, drug maker Mylan Laboratories Inc. will receive nearly $38 million from German rival Schwarz Pharma AG to end the companies’ litigation over heartburn medicine Prilosec.
Mylan Laboratories Inc. has sued the U.S. Food and Drug Administration for delaying introduction of the company's generic version of Johnson & Johnson’s Duragesic pain-relief skin patch.
Japanese pharmaceutical and brewing company Kirin Brewery has settled its litigation against Geron Corp. over development rights to cancer vaccines.
Israel-based Lumenis Ltd. has agreed to pay rival Palomar Medical Technologies $4.1 million to settle a patent lawsuit over aesthetic laser devices.
A patent infringement lawsuit filed by Kos Pharma against Barr Labs over a cholesterol drug has been consolidated with the three previously consolidated lawsuits.
Medical device maker Inamed Corp. will pay $17.2 million to settle Johnson & Johnson unit Ethicon Endo-Surgery’s patent infringement lawsuit related to an obesity treatment known as gastric banding, the company said Monday.
Biotech and pharmaceutical companies are patenting less but litigating more, according to a report on biotech patent trends.
Energizer Holdings Inc. has filed a countersuit against Gillette Co. over four Gillette patents for diamond coating on razors.
The maker of the Botox anti-wrinkle treatment has won a $1.5 million judgment against a company that marketed a product with a confusingly similar name.
General-practice firm Jenner & Block will become a force to be reckoned with in Chicago’s intellectual property field with the acquisition of IP specialty firm Roper & Quigg.
A federal court has issued a permanent injunction barring sales of Smith & Nephew surgical devices that infringe ArthroCare's patents, after the Federal Circuit Court of Appeals denied Smith & Nephew's motion to delay enforcement of the injunction pending appeal, Arthrocare said.
Andrx Corp. will pay Kos Pharmaceuticals $6 million and agree to stop using the Altocor trademark for any of its products under a settlement agreement between the two companies.
Andrx Corp. does not infringe a patent that Bristol-Myers Squibb Co. holds for its Monopril hypertension drug, a federal judge has ruled in a decision that clears the way for Andrx to sell generic version of the product.